Trial intelligence / Profile preview

Bioequivalence Study of Entecavir 0.5 mg Film-coated Tablets in Healthy Thai Volunteers

TCTR20210709001Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of entecavir in hepatitis B (HBV) (2 arms), sponsored by International Bio Service. Planned start Oct 2021; status: not yet recruiting.

02

Drugs

entecavir
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on TCTR20210709001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210709001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call